“…Therefore, it has been proposed that both groups of patients may benefit from 1 -PI augmentation therapy to prevent the deleterious effect of free protease (Allen, 1996;Birrer, 1995;Birrer et al, 1996) However, intravenous administration of 1 -PI did not result in a suppression of the respiratory neutrophil elastase burden (McElvaney et al, 1991). Several studies have been conducted using inhalation of an aerosolized 1 -PI in cystic fibrosis and 1 -PI deficiency Griese et al, 2001Griese et al, , 2007Martin et al, 2006;Brand et al, 2009). Whereas several studies that investigated the efficacy of treatment with an aerosolized 1 -PI both in patients with cystic fibrosis and in those with 1 -PI deficiency came to positive conclusions regarding deposition of inhaled 1 -PI in the lungs and its anti-elastase activity (see review by Siekmeier, 2010), the conclusion from other studies was that treatment with 1 -PI did not demonstrate any clinical improvements (Martin, 2006).…”